最新动态

最新净值:2.1429 -0.0766(-3.45%)

累计净值:2.1429

更新时间:2026-08-28 15:00

分红详情>> 基金概要
投资类型:股票型 易方达标普生物科技指数(QDII-LOF)A(人民币份额)增长自成立以来,共分红 0
基金经理:宋钊贤
基金规模:2.70亿元
    易方达标普生物科技指数(QDII-LOF)A(人民币份额)基金收益率排名表
  • 一年以上
  • 一年以内
项目 一周收益(%) 一月收益(%) 三月收益(%) 半年收益(%) 今年以来收益(%)
收益率 -2.03 7.51 17.09 22.12 25.00
股票型名次 3122 532 118 173 302
十大重仓股
  • 2026-06-30
股票名称 股票代码 持有量(万股) 市值(万元) 占净值
Apogee Therapeutics APGE US 0.47 425.43 1.41%
Apogee Therapeutics Inc APGE US 0.47 425.43 1.41%
Moderna MRNA US 0.85 403.71 1.34%
Moderna MRNA US 0.85 403.71 1.34%
Twist Bioscience Corp TWST US 0.57 402.49 1.33%
Twist Bioscience TWST US 0.57 402.49 1.33%
Oruka Therapeutics ORKA US 0.61 394.04 1.31%
Oruka Therapeutics Inc ORKA US 0.61 394.04 1.31%
Kymera Therapeutics KYMR US 0.50 388.63 1.29%
Kymera Therapeutics Inc KYMR US 0.50 388.63 1.29%
Viking Therapeutics VKTX US 1.40 372.66 1.24%
Viking Therapeutics Inc VKTX US 1.40 372.66 1.24%
Praxis PRAX US 0.16 368.94 1.22%
Praxis Precision Medicines Inc PRAX US 0.16 368.94 1.22%
Erasca ERAS US 2.91 363.25 1.20%
Erasca Inc ERAS US 2.91 363.25 1.20%
Revolution Medicines RVMD US 0.27 344.40 1.14%
REVOLUTION Medicines Inc RVMD US 0.27 344.40 1.14%
Rhythm Pharmaceuticals Inc RYTM US 0.45 343.47 1.14%
CG oncology Inc CGON US 0.71 342.95 1.14%
Rhythm RYTM US 0.45 343.47 1.14%
Vaxcyte Inc PCVX US 0.86 339.30 1.13%
SELLAS Life Sciences Group Inc SLS US 3.38 340.04 1.13%
Cytokinetics Inc CYTK US 0.58 336.76 1.12%
Dianthus Therapeutics Inc DNTH US 0.51 338.20 1.12%
Natera Inc NTRA US 0.18 332.42 1.10%
Scholar Rock Holding Corp SRRK US 0.88 330.70 1.10%
Roivant Sciences Ltd ROIV US 1.37 330.22 1.10%
Mirum Pharmaceuticals Inc MIRM US 0.41 330.18 1.10%
Cogent Biosciences Inc COGT US 1.24 326.95 1.08%
Ultragenyx Pharmaceutical Inc RARE US 1.43 325.98 1.08%
Travere Therapeutics Inc TVTX US 0.83 322.23 1.07%
Alkermes PLC ALKS US 0.89 316.85 1.05%
Krystal Biotech Inc KRYS US 0.12 315.41 1.05%
Celcuity Inc CELC US 0.44 314.31 1.04%
TG Therapeutics Inc TGTX US 0.83 312.41 1.04%
Relay Therapeutics Inc RLAY US 2.46 314.06 1.04%
Spyre Therapeutics Inc SYRE US 0.52 313.46 1.04%
Beam Therapeutics Inc BEAM US 1.32 308.53 1.02%
Protagonist Therapeutics Inc PTGX US 0.37 307.24 1.02%
Insmed Inc INSM US 0.42 307.68 1.02%
Arrowhead Pharmaceuticals Inc ARWR US 0.55 305.50 1.01%
Madrigal Pharmaceuticals Inc MDGL US 0.08 302.08 1.00%
Vertex Pharmaceuticals Inc VRTX US 0.09 302.46 1.00%
Vera Therapeutics Inc VERA US 1.04 302.75 1.00%
Halozyme Therapeutics Inc HALO US 0.55 294.32 0.98%
AbbVie Inc ABBV US 0.17 296.68 0.98%
PTC Therapeutics Inc PTCT US 0.53 294.84 0.98%
Biogen Inc BIIB US 0.20 294.90 0.98%
uniQure NV QURE US 0.94 293.88 0.97%
Bridgebio Pharma Inc BBIO US 0.58 292.95 0.97%
ImmunityBio Inc IBRX US 4.88 291.26 0.97%
CRISPR Therapeutics AG CRSP US 0.79 292.46 0.97%
Summit Therapeutics Inc SMMT US 2.91 289.11 0.96%
Ionis Pharmaceuticals Inc IONS US 0.53 286.71 0.95%
Incyte Corp INCY US 0.37 285.21 0.95%
Amgen Inc AMGN US 0.12 284.37 0.94%
Neurocrine Biosciences Inc NBIX US 0.24 277.79 0.92%
Alnylam Pharmaceuticals Inc ALNY US 0.13 274.12 0.91%
Exelixis Inc EXEL US 0.74 274.34 0.91%
投资行业组合 市值(亿元) 占净值
保健 2.86 94.71%
基金评级
评级机构 星级 星级占比 说明
济安金信
占济安金信评级基金总数中间位置的35%
截止日期:2026-06-30评级说明
基金资讯
更多>> 基金新闻
更多>> 基金公告